Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
774.4 USD | -1.61% | +0.44% | +32.94% |
04:53pm | Eli Lilly: research collaboration with Totus Medicines | CF |
04:25pm | Eli Lilly: positive trials in type 2 diabetes | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.94% | 71TCr | |
+30.77% | 60TCr | |
-1.75% | 37TCr | |
+20.18% | 33TCr | |
+5.99% | 29TCr | |
+14.77% | 24TCr | |
+9.13% | 21TCr | |
-3.97% | 20TCr | |
+9.39% | 17TCr | |
+0.52% | 16TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company, Q4 2022 Earnings Call, Feb 02, 2023